Oncocyte OCX
1346.12
14.62
1.07
%
已收盤：03/21 20:00 (臺灣)
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q3 | 2.85 | 100.39 | -1.04 | -13,515 | -13 | |
| 2024Q2 | 2.95 | 102.43 | -0.19 | -4,632 | -5 | |
| 2024Q1 | 2.93 | 101.68 | -1.13 | -9,267 | -9 | |
| 2023Q4 | 2.50 | 93.73 | -2.07 | -16,179 | -16 | |
| 2023Q3 | 3.12 | 82.39 | -0.85 | -6,513 | -6 | |
| 2023Q2 | 4.60 | 86.23 | -1.23 | -8,294 | -8 | |
| 2023Q1 | 7.09 | 125.12 | 0.40 | 5,798 | 3 | |
| 2022Q4 | 6.42 | 97.03 | -8.03 | -11,648 | -45 | |
| 2022Q3 | 14.60 | 99.58 | -1.59 | -23,035 | -9 | |
| 2022Q2 | 17.99 | 121.07 | -1.43 | -1,626 | -8 | |
| 2022Q1 | 29.80 | 89.18 | -2.20 | -3,017 | -10 | |
| 2021Q4 | 43.40 | 99.82 | -8.00 | -35,680 | -36 | |
| 2021Q3 | 71.20 | 98.94 | -3.00 | -13,604 | -14 | |
| 2021Q2 | 114.80 | 110.87 | -2.40 | -13,568 | -10 | |
| 2021Q1 | 103.80 | 101.93 | -1.00 | -11,360 | -4 | |
| 2020Q4 | 47.80 | 105.22 | -2.00 | -6,267 | -6 | |
| 2020Q3 | 27.80 | 100.34 | -2.00 | -6,244 | -7 | |
| 2020Q2 | 38.20 | 100.42 | -2.60 | -8,769 | -9 | |
| 2020Q1 | 49.00 | 99.47 | -2.60 | -8,431 | -8 | |
| 2019Q4 | 45.00 | 97.83 | -3.00 | -7,523 | -8 |
